MarketPeel
Chief Executive Officer
Wed, Jul 8, 2026
Jul 8
sold $784.78k of SNDX
32,375 shares @ $24.24
Decreased holdings by -6.30%
Net across this filing: 0.00% (+0 shares)
12th largest trade (out of 109)
Planned (10b5-1)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 1,564,551 options to purchase shares of common stock that are vested and immediately exercisable and a total of 813,949 options to purchase shares of common stock that have not yet vested.Form 4 footnote
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Net holdings across this filing: +0.0% (+0 shares)
Price 24% above 200-day moving average
SNDXSyndax Pharmaceuticals Inc
HealthcareBiotechnology
1D0.00%
1W-0.56%
1M-5.57%
3M-1.26%
6M
1Y

Recent insider activity at SNDX

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback